Home524711 • BOM
add
Vista Pharmaceuticals Ltd
Previous close
₹6.80
Day range
₹6.73 - ₹7.45
Year range
₹6.57 - ₹13.09
Market cap
458.56M INR
Avg Volume
10.41K
P/E ratio
-
Dividend yield
-
Primary exchange
BOM
Market news
MarketBeat
15 minutes ago
Cytokinetics (NASDAQ:CYTK) Given New $84.00 Price Target at Leerink Partners
0.41%
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 24.18M | -5.35% |
Operating expense | 33.50M | 90.01% |
Net income | -23.19M | -75.41% |
Net profit margin | -95.91 | -85.33% |
Earnings per share | — | — |
EBITDA | -30.08M | -97.42% |
Effective tax rate | 29.30% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.33M | -94.97% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 446.39M | — |
Shares outstanding | 56.57M | — |
Price to book | 0.94 | — |
Return on assets | — | — |
Return on capital | -15.02% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -23.19M | -75.41% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1991
Website
Employees
30
